Pretreatment platelet count predicts survival outcome of patients with de novo non-M3 acute myeloid leukemia

BACKGROUND: Pretreatment platelet count has been reported as a potential tool to predict survival outcome in several solid tumors. However, the predictive value of pretreatment platelet count remains obscure in de novo acute myeloid leukemia (AML) excluding acute promyelocytic leukemia (M3). METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qianying, Dai, Kanchun, Bi, Laixi, Jiang, Songfu, Han, Yixiang, Yu, Kang, Zhang, Shenghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2017
Materias:
Hematology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742276/
https://www.ncbi.nlm.nih.gov/pubmed/29302387
http://dx.doi.org/10.7717/peerj.4139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742276/
https://www.ncbi.nlm.nih.gov/pubmed/29302387
http://dx.doi.org/10.7717/peerj.4139

Ejemplares similares